Global Natural Killer Cell Therapy Market Growth (Status and Outlook) 2023-2029

Global Natural Killer Cell Therapy Market Growth (Status and Outlook) 2023-2029

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
LPI (LP Information)' newest research report, the “Natural Killer Cell Therapy Industry Forecast” looks at past sales and reviews total world Natural Killer Cell Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Natural Killer Cell Therapy sales for 2023 through 2029. With Natural Killer Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Natural Killer Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global Natural Killer Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Natural Killer Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Natural Killer Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Natural Killer Cell Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Natural Killer Cell Therapy.
The global Natural Killer Cell Therapy market size is projected to grow from US$ 250.2 million in 2022 to US$ 1200.2 million in 2029; it is expected to grow at a CAGR of 25.1% from 2023 to 2029.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
This report presents a comprehensive overview, market shares, and growth opportunities of Natural Killer Cell Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
NK Cell Therapies
NK Cell Directed Antibodies
Segmentation by application
Cancer
Gastrointestinal Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest

Please note: The report will take approximately 2 business days to prepare and deliver.